British journal of cancer · 1989

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.

Название и аннотация: Перевод в очереди

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Morrison JM, Howell A, Kelly KA, Grieve RJ, Monypenny IJ, Walker RA, Waterhouse JA

Аннотация

The aim of this study was to test the effectiveness of a regimen of combination chemotherapy when given as an adjuvant treatment after mastectomy to patients with histologically negative axillary lymph nodes. A total of 574 patients with cancer of the breast and no involvement of axillary lymph nodes were randomised, after simple mastectomy with axillary sampling, to receive either no adjuvant treatment or oral fluorouracil 500 mg, methotrexate 25 mg and chlorambucil 10 mg p.o. on day 1 and fluorouracil 500 mg and chlorambucil 10 mg p.o. on day 2 (LMF) every 21 days for eight cycles. Randomisation was stratified according to menopausal status and tumour size. Treatment was started within 14 days of surgery in 97% of patients. Ninety per cent of patients received eight cycles of chemotherapy with no dose reduction. At a median follow-up of 7 years, there was no evidence that relapse-free or overall survival time were influenced by treatment.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ .

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43.

Elston C. W., Gresham G. A., Rao G. S., Zebro T., Haybittle J. L., Houghton J., Kearney G. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer. 1982 May;45(5):655–669. doi: 10.1038/bjc.1982.106.

Fisher B., Redmond C., Dimitrov N. V., Bowman D., Legault-Poisson S., Wickerham D. L., Wolmark N., Fisher E. R., Margolese R., Sutherland C. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. doi: 10.1056/NEJM198902233200801.

Forrest A. P., Roberts M. M., Cant E., Shivas A. Simple mastectomy and pectoral node biopsy. Br J Surg. 1976 Aug;63(8):569–575. doi: 10.1002/bjs.1800630802.

Friedman M. A., Dorr F. A., Perloff M. Adjuvant therapy for breast cancer patients with negative lymph nodes. NCI Monogr. 1986;(1):139–144.

Koyama H., Wada T., Takahashi Y., Nishizawa Y., Iwanaga T., Aoki Y., Terasawa T., Kosaki G., Kajita A., Wada A. Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer. Cancer. 1980 Dec 1;46(11):2373–2379. doi: 10.1002/1097-0142(19801201)46:11<2373::aid-cncr2820461112>3.0.co;2-h.

Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803.

McGuire W. L., DeLaGarza M. Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J Clin Endocrinol Metab. 1973 Dec;37(6):986–989. doi: 10.1210/jcem-37-6-986.

Nissen-Meyer R., Høst H., Kjellgren K., Månsson B., Norin T. Treatment of node-negative breast cancer patients with short course of chemotherapy immediately after surgery. NCI Monogr. 1986;(1):125–128.

Semiglazov V. F., Bavli J. L., Moiseyenko V. M., Rzhankov S. V., Migmanova N. S., Popova R. T., Seleznyov I. K., Kremen B. V., Kostetskaya T. V., Barash N. J. Clinical trials on adjuvant chemotherapy for breast cancer. Cancer. 1986 May 15;57(10):1957–1960. doi: 10.1002/1097-0142(19860515)57:10<1957::aid-cncr2820571012>3.0.co;2-a.

Senn H. J., Jungi W. F., Amgwerd R., Hochuli E., Ammann J., Engelhart G., Heinz C., Wick A., Enderlin F., Creux G. Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results. NCI Monogr. 1986;(1):129–134.

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.

Ошибки и ограничения

Аннотация

Selected References